New class of gammadelta T cells activators and use thereof

Details for Australian Patent Application No. 2006228435 (hide)

Owner Innate Pharma

Inventors Belmant, Christian

Agent Davies Collison Cave

Pub. Number AU-B-2006228435

PCT Pub. Number WO2006/103568

Priority 60/663,726 22.03.05 US

Filing date 21 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 10 November 2011

International Classifications

C07F 9/02 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/66 (2006.01) - Phosphorus compounds

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/103568 Priority application(s): WO2006/103568

10 November 2011 Application Accepted

  Published as AU-B-2006228435

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228511-Steering system and method for a guided flying apparatus

2006228426-Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia